MiniMed, German Firm to Develop Glucose Device

MiniMed Inc. in Sylmar has reached agreement with German-based Boehringer Mannheim Corp. to develop and market a new device to be used in hospitals to manage glucose levels in patients.

The device will be submitted to the U.S. Food and Drug Administration for approval.

MiniMed is a maker of infusion systems used primarily in the treatment of diabetes.